Capsule Endoscopy Market Report 2025

This Capsule Endoscopy market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The capsule endoscopy market size has grown rapidly in recent years. It will grow from $0.69 billion in 2024 to $0.76 billion in 2025 at a compound annual growth rate (CAGR) of 11.14%. The growth during the historic period can be attributed to the rising prevalence of gastrointestinal disorders, the growing preference for non-invasive diagnostic methods, an expanding aging population, heightened awareness of gastrointestinal conditions, and increased focus on healthcare awareness.

The capsule endoscopy market size is expected to see rapid growth in the next few years. It will grow to $1.15 billion in 2029 at a compound annual growth rate (CAGR) of 10.88%. The growth anticipated during the forecast period can be credited to the expansion of telemedicine and mobile health solutions, increased adoption of minimally invasive medical technologies, a growing preference for outpatient procedures, rising demand for early diagnosis, and an increasing need for patient-friendly diagnostic tools. Key trends expected during this period include advancements in technology, innovations in capsule design, the development of minimally invasive procedures, integration with artificial intelligence, and progress in biodegradable capsule technology.

The increasing prevalence of gastrointestinal illnesses is anticipated to drive the growth of the capsule endoscopy market. Gastrointestinal disorders, including indigestion, inflammatory bowel disease (IBD), and gastrointestinal cancers, are conditions that affect the digestive system. Factors contributing to the rising prevalence of these illnesses include poor dietary habits, stress, sedentary lifestyles, overuse of antibiotics, aging populations, environmental contaminants, antibiotic resistance, and disruptions to the gut microbiome. Capsule endoscopy offers a non-invasive and detailed examination of the gastrointestinal tract, aiding in the early detection and management of conditions such as Crohn’s disease, ulcers, and gastrointestinal bleeding. For example, the IBD Registry, a UK-based non-profit organization, reported in December 2023 that over 5,300 individuals were registered with Inflammatory Bowel Disease, marking an increase of more than 3,000 members compared to the previous year. This growing prevalence of gastrointestinal illnesses is therefore boosting the demand for capsule endoscopy solutions.

Companies in the capsule endoscopy market are increasingly investing in innovative technologies, such as magnetically controlled capsule endoscopy systems, to enhance diagnostic precision, improve patient experience, and broaden applications for gastrointestinal imaging. These advanced systems utilize external magnetic fields to navigate a swallowable camera capsule through the gastrointestinal tract for detailed imaging. For instance, in February 2023, AnX Robotica Corporation, a US-based equipment manufacturer, introduced the NaviCam Small Bowel System. This system is designed to optimize the visualization of the small bowel, an essential area for diagnosing various gastrointestinal conditions. Featuring high-definition imaging, real-time navigation capabilities, and AI-powered analytics, the system ensures rapid and accurate detection of abnormalities while maintaining a non-invasive approach. This cutting-edge technology establishes a new standard for efficiency and effectiveness in gastrointestinal healthcare.

In December 2022, AnX Robotica Corporation announced a partnership with GastroGPO LLC to enhance access to sedation-free, minimally invasive endoscopy solutions. Through this collaboration, GastroGPO members can utilize the NaviCam Magnetically Controlled Capsule Endoscopy System (MCCE), which enables examinations of the esophagus and stomach without the need for sedation. GastroGPO LLC, a US-based specialty networks company, leverages collective purchasing power to provide gastroenterology practices with cost-effective access to advanced capsule endoscopy equipment.

Major players in the capsule endoscopy market are Medtronic plc, Fujifilm Holdings Corporation, Boston Scientific Corporation, Olympus Corporation, STERIS plc, Given Imaging Ltd., Check-Cap Ltd., Micro-Tech Endoscopy, CapsoVision Inc., Stratis Medical Inc., IntroMedic Co. Ltd., RF System Lab Co. Ltd., Ankon Technologies Co. Ltd., AnX Robotica Corporation, AccuRead Endoscopy Inc., Chongqing Jinshan Science & Technology Group Co. Ltd., BioCam, SynMed Medical Technology Co. Ltd., Anhan Technology Co. Ltd., Shengxian Minimal Invasive Inc.

North America was the largest region in the capsule endoscopy market in 2024. The regions covered in capsule endoscopy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the capsule endoscopy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Capsule endoscopy is a minimally invasive diagnostic technique involving the ingestion of a small, pill-sized camera designed to capture images of the gastrointestinal (GI) tract. This procedure is utilized to identify conditions such as bleeding, ulcers, and inflammatory bowel diseases, offering detailed visuals of areas that are challenging to reach with conventional endoscopy.

The key components of capsule endoscopy include capsule endoscopes, and systems. Capsule endoscopes are compact, pill-shaped devices equipped with cameras that are swallowed to record images of the digestive tract for diagnosing various gastrointestinal conditions. These devices are employed in multiple applications, such as obscure gastrointestinal bleeding (OGIB), Crohn's disease, small intestine tumors, and more. They are commonly used by hospitals, diagnostic laboratories, and specialty clinics.

The capsule endoscopy market research report is one of a series of new reports that provides capsule endoscopy market statistics, including the capsule endoscopy industry global market size, regional shares, competitors with the capsule endoscopy market share, detailed capsule endoscopy market segments, market trends, and opportunities, and any further data you may need to thrive in the capsule endoscopy industry. This capsule endoscopy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The capsule endoscopy market consists of sales of image recorder, software for image analysis, data management systems, retrieval kits, and biopsy tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.